Whitepapers

Feb 01, 2018
Sponsored Content
Clinical research sites have a tough, but critically important, job. We need research sites to help us develop and test new therapies, and to bring new treatments to patients. It’s rigorous and precise work, but essential to the progress of medicine—and important to the patients who want the option to participate in clinical research. So, what are the things that high-performing clinical research sites do that make sponsors return to them again and again?
Feb 01, 2018
Sponsored Content
With the help of Sanofi, BMS and Microsoft, our latest trends report explores the latest innovations in disruptive technologies and how these can help you better engage with your customers.
Feb 01, 2018
Sponsored Content
To unleash the pharma’s full potential, we need to say goodbye to sales and marketing conflicts and embrace one, truly integrated customer-centric approach. In eyeforpharma’s latest white paper, AstraZeneca, Bristol Myers-Squibb, Janssen, and Merck Serono explain how you can fuse your commercial function.
Jan 24, 2018
Sponsored Content
By Merck
A guidebook to today’s biopharma executives seeking to successfully bring a molecule to the clinic.
Jan 24, 2018
Sponsored Content
A guidebook to today’s biopharma executives seeking to successfully bring a molecule to the clinic.
Jan 01, 2018
Sponsored Content
Packed with business acumen. Data-driven. Agile. This is the future of the sales force, as told by leading sales excellence leaders from UCB, Novartis and Roche Diabetes Care. Find out more in eyeforpharma’s latest white paper, The Data Driven Rep.
Jan 01, 2018
Sponsored Content
This white paper provides patient perspectives on direct-to-consumer advertising, including exclusive results from the “DTC Attitudes, Behaviours and Preferences” study plus contributions from Astellas, Takeda and Astrazeneca.
Jan 01, 2018
Sponsored Content
This case history demonstrates how AI can be used to identify patients with severe, uncontrolled asthma earlier, allowing higher-potency medications to be administered sooner.
Dec 20, 2017
Sponsored Content
By Merck
In this guidebook, our experts share some key considerations for designing, building and operating an agile and flexible cGMP biomanufacturing facility. To achieve this goal, companies must first overcome some common roadblocks and navigate the complexities associated with business planning, technology, regulatory/risk assessment and engineering.
Dec 18, 2017
Sponsored Content
In this guidebook, our experts share some key considerations for designing, building and operating an agile and flexible cGMP biomanufacturing facility. To achieve this goal, companies must first overcome some common roadblocks and navigate the complexities associated with business planning, technology, regulatory/risk assessment and engineering.
native1_300x100
lorem ipsum